| Identification | Back Directory | [Name]
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- | [CAS]
2421153-77-5 | [Synonyms]
ET-JQ1-OH
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-α-ethyl-2,3,9-trimethyl-, (αR,6S)- | [Molecular Formula]
C21H21ClN4O2S | [MOL File]
2421153-77-5.mol | [Molecular Weight]
428.94 |
| Chemical Properties | Back Directory | [Boiling point ]
663.8±65.0 °C(Predicted) | [density ]
1.44±0.1 g/cm3(Predicted) | [solubility ]
Soluble to 100 mM in DMSO | [pka]
4.11±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
ET-JQ1-OH is an allele-specific BET inhibitor[1]. | [Biological Activity]
(+)-JQ1 bump, acid functionalized is a BET bromodomain binding analog of (+)-JQ1 that selectively binds single point mutant form of Brd4 (Brd4BD2 L387A). Functionalized with a carboxylic acid group to enable onward chemistry. The position of the carboxylic acid group represents an 'exit vector' allowing modification without interfering with compound binding ability. | [storage]
Store at -20°C | [References]
[1] Bond AG, et al. Stereoselective synthesis of allele-specific BET inhibitors. Org Biomol Chem. 2020 Oct 7;18(38):7533-7539. DOI:10.1039/d0ob01165g |
|
|